NEXGEL, INC.
NXGL · XNASCIK 1468929fmd_0411104RHB3X10Y4G10MYPHBM6Manufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2018 to Jun 30, 2026, 34 periods
Latest annual · FY2025
Millions- Total revenues
- 11
- Gross profit
- 5
- Operating income
- (3)
- Net income
- (3)
- Free cash flow
- (1)
Latest quarter · Q2 FY2026
Millions- Total revenues
- 4
- Gross profit
- 1
- Operating income
- (3)
- Net income
- (4)
- Free cash flow
- (1)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2022 to FY2025
- +77.3%
- Revenue, 5 yearsFY2020 to FY2025
- +76.1%
- Net income, 5 yearsFY2020 to FY2025
- n/m
NEXGEL, INC. (NXGL) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Revenue | $11.4 million | $8.7 million | +31.5% | 10-K 2026-03-31 · proof |
| Gross profit | $4.5 million | $2.7 million | +64.1% | 10-K 2026-03-31 · proof |
| Operating income | -$3.4 million | -$3.6 million | 10-K 2026-03-31 · proof | |
| Net income | -$3 million | -$3.3 million | 10-K 2026-03-31 · proof | |
| Cash from operating activities | -$1.3 million | -$3.9 million | 10-K 2026-03-31 · proof | |
| Free cash flow | -$1.4 million | -$4.3 million | 10-K 2026-03-31 · proof | |
| Total assets | $10.5 million | $11 million | -4.8% | 10-K 2026-03-31 · proof |
| Total liabilities | $5.6 million | $4.9 million | +13.6% | 10-K 2026-03-31 · proof |
| Cash and cash equivalents | $317,000 | $1.8 million | -82.5% | 10-K 2026-03-31 · proof |
- What was NEXGEL, INC. (NXGL)'s revenue in fiscal 2025?
- NEXGEL, INC. (NXGL) reported revenue of $11.4 million for fiscal 2025 (the year ended Dec 31, 2025), against $8.7 million the year before (+31.5%). Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
- What was NEXGEL, INC. (NXGL)'s gross profit in fiscal 2025?
- NEXGEL, INC. (NXGL) reported gross profit of $4.5 million for fiscal 2025 (the year ended Dec 31, 2025), against $2.7 million the year before (+64.1%). Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
- What was NEXGEL, INC. (NXGL)'s operating income in fiscal 2025?
- NEXGEL, INC. (NXGL) reported operating income of -$3.4 million for fiscal 2025 (the year ended Dec 31, 2025), against -$3.6 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
- What was NEXGEL, INC. (NXGL)'s net income in fiscal 2025?
- NEXGEL, INC. (NXGL) reported net income of -$3 million for fiscal 2025 (the year ended Dec 31, 2025), against -$3.3 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
- What was NEXGEL, INC. (NXGL)'s cash from operating activities in fiscal 2025?
- NEXGEL, INC. (NXGL) reported cash from operating activities of -$1.3 million for fiscal 2025 (the year ended Dec 31, 2025), against -$3.9 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
- What was NEXGEL, INC. (NXGL)'s free cash flow in fiscal 2025?
- NEXGEL, INC. (NXGL) reported free cash flow of -$1.4 million for fiscal 2025 (the year ended Dec 31, 2025), against -$4.3 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
- What are NEXGEL, INC. (NXGL)'s total assets?
- As of Dec 31, 2025, NEXGEL, INC. (NXGL) reported total assets of $10.5 million, against $11 million a year earlier (-4.8%). Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
- What are NEXGEL, INC. (NXGL)'s total liabilities?
- As of Dec 31, 2025, NEXGEL, INC. (NXGL) reported total liabilities of $5.6 million, against $4.9 million a year earlier (+13.6%). Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
- What are NEXGEL, INC. (NXGL)'s cash and cash equivalents?
- As of Dec 31, 2025, NEXGEL, INC. (NXGL) reported cash and cash equivalents of $317,000, against $1.8 million a year earlier (-82.5%). Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:NXGL&period_type=annual&limit=5"Information only, not investment advice.